Prospects for histomorphological and genetic diagnosis of autopsy-negative sudden cardiac death

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This article presents the prospects of histological and genetic diagnosis in cases of sudden cardiac death where primary autopsy findings do not reveal obvious pathological changes.

In recent years, the number of autopsy-negative sudden cardiac deaths has increased, creating a need for more precise diagnostic methods to determine the cause of death and potentially prevent such cases in the future. The article examines modern histological examination techniques for cardiac tissues, as well as molecular genetic testing approaches that may be useful in identifying subclinical conditions leading to sudden cardiac death.

Molecular genetic methods for investigating sudden cardiac death remain underexplored. To date, large-scale studies on the molecular genetic causes of such fatalities are lacking in Russia, highlighting the need for further research at the intersection of medical genetics, pathological anatomy, and forensic medicine.

This article provides a brief review of histological and genetic diagnosis of sudden cardiac death, where the authors propose integrating these methods into the diagnostic process to enhance their effectiveness in pathological and forensic medical practice. The authors emphasize the necessity of further research, including the application of advanced technologies in histological and genetic analysis, as well as big data analytics to identify new pathological mechanisms of sudden cardiac death.

Medical genetic counseling on predisposition to sudden cardiac death can help identify at-risk individuals and reduce mortality. In the future, it may become possible to establish links between genetic predictors of sudden cardiac death and defects in myocardial contractile protein expression, with subsequent confirmation using immunohistochemical analysis.

Full Text

Restricted Access

About the authors

Boris N. Kulbitskiy

Petrovsky National Research Centre of Surgery

Email: kulbitskiybn@rambler.ru
ORCID iD: 0000-0001-7791-3041
SPIN-code: 7785-0838

MD, Cand. Sci. (Medicine)

Россия, Moscow

Olga A. Vladykina

North-Western State Medical University named after I.I. Mechnikov

Email: olavtryggvason@yandex.ru
ORCID iD: 0009-0001-4136-8691
Россия, Saint Petersburg

Dmitry V. Bogomolov

Petrovsky National Research Centre of Surgery

Email: usicc@yandex.ru
ORCID iD: 0000-0002-9111-8623
SPIN-code: 2777-2674

MD, Dr. Sci. (Medicine)

Россия, Moscow

Anastasya I. Kadykova

Federal Research and Clinical Center of Sports Medicine and Rehabilitation

Email: KadykovaAI@sportfmba.ru
ORCID iD: 0000-0003-2996-6194
SPIN-code: 8764-6577
Россия, Moscow

Roman V. Deev

Petrovsky National Research Centre of Surgery; Federal Research and Clinical Center of Sports Medicine and Rehabilitation

Author for correspondence.
Email: romdey@gmail.com
ORCID iD: 0000-0001-8389-3841
SPIN-code: 2957-1687

MD, Cand. Sci. (Medicine), Assistant Professor

Россия, Moscow; Moscow

References

  1. Shlyakhto EV, Arutyunov GP, Belenkov YN, et al. National recommendations on the determination of risk and prevention of sudden cardiac death. 2nd ed. Moscow: Medpraktika-M; 2018. 247 р. (In Russ.) EDN: OGIVYR
  2. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death ― executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27(17):2099–2140. doi: 10.1093/eurheartj/ehl199
  3. Priori SG, Blomstrom-Lundqvist C. 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J. 2015;36(41):2757–2759. doi: 10.1093/eurheartj/ehv445
  4. Bayes de Luna A, Elosua R. Sudden death (In English, Spanish). Rev Esp Cardiol (Engl Ed). 2012;65(11):1039–1052. doi: 10.1016/j.recesp.2012.03.032
  5. Zimmerman DS, Tan HL. Epidemiology and risk factors of sudden cardiac arrest. Curr Opin Crit Care. 2021;27(6):613–616. doi: 10.1097/MCC.0000000000000896
  6. Stiles MK, Wilde AA, Abrams DJ, et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm. 2021;18(1):e1–e50. doi: 10.1016/j.hrthm.2020.10.010
  7. Lou J, Chen H, Huang S, et al. Update on risk factors and biomarkers of sudden unexplained cardiac death. J Forensic Leg Med. 2022;87:102332. doi: 10.1016/j.jflm.2022.102332
  8. Fitzgerald DA, Jeffery H, Arbuckle S, et al. Sudden Unexpected Death in Infancy [SUDI]: What the clinician, pathologist, coroner and researchers want to know. Paediatr Respir Rev. 2022;41:14–20. doi: 10.1016/j.prrv.2021.08.002
  9. Grassi S, Vidal MC, Campuzano O, et al. Sudden death without a clear cause after comprehensive investigation: An example of forensic approach to atypical/uncertain findings. Diagnostics (Basel). 2021;11(5):886. doi: 10.3390/diagnostics11050886
  10. Revishvili ASh, Neminushchiy NM, Batalov RE, et al. All-Russian clinical recommendations on the control of the risk of sudden cardiac arrest and sudden cardiac death, prevention and first aid. J Arrhythmology. 2017;(89):2–104. (In Russ.) EDN: YPIPVV
  11. Shankar R, Donner EJ, McLean B, et al. Sudden unexpected death in epilepsy (SUDEP): What every neurologist should know. Epileptic Disord. 2017;19(1):1–9. doi: 10.1684/epd.2017.0891
  12. Sahly AN, Shevell M, Sadleir LG, Myers KA. SUDEP risk and autonomic dysfunction in genetic epilepsies. Auton Neurosci. 2022;237:102907. doi: 10.1016/j.autneu.2021.102907
  13. Van der Werf C, Hendrix A, Birnie E, et al. Improving usual care after sudden death in the young with focus on inherited cardiac diseases (the CAREFUL study): A community-based intervention study. Europace. 2016;18(4):592–601. doi: 10.1093/europace/euv059
  14. Gavrilova EA, Churganov OA, Belodedova MD. Autopsy-negative cardiac death in sports and its causes. Human Physiology. 2021;47(2):232–236. EDN: HMHOCI doi: 10.31857/S0131164621010045
  15. Sheppard MN. Aetiology of sudden cardiac death in sport: A histopathologist's perspective. Br J Sports Med. 2012;46(Suppl 1):i15–i21. doi: 10.1136/bjsports-2012-091415
  16. Marijon E, Uy-Evanado A, Reinier K, et al. Sudden cardiac arrest during sports activity in middle age. Circulation. 2015;131(16):1384–1391. doi: 10.1161/CIRCULATIONAHA.114.011988
  17. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: A decade in review. Circulation. 2015;132(1):10–19. doi: 10.1161/CIRCULATIONAHA.115.015431
  18. Finocchiaro G, Papadakis M, Robertus JL, et al. Etiology of sudden death in sports: Insights from a United Kingdom regional registry. J Am Coll Cardiol. 2016;67(18):2108–2115. doi: 10.1016/j.jacc.2016.02.062
  19. Emery MS, Kovacs RJ. Sudden cardiac death in athletes. JACC Heart Fail. 2018;6(1):30–40. doi: 10.1016/j.jchf.2017.07.014
  20. Pigolkin YuI, Shilova MA, Berezovsky DP, et al. Molecular and genetic basis of sudden cardiac death of young-aged individuals with cardiomyopathy of different genesis. Forensic Medical Examination. 2019;62(3):48–53. EDN: HSDZOZ doi: 10.17116/sudmed20196203148
  21. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326(4):242–250. doi: 10.1056/NEJM199201233260406
  22. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e651. doi: 10.1161/CIR.0000000000000617
  23. Kumar V, Abbas AK, Aster JC. Robbins and Cotran pathologic basis of disease [June 2, 2014]. 9th ed. Elsevier Health Sciences; 2014. 1472 р.
  24. Braunwald E. Cardiomyopathies: An overview. Circ Res. 2017;121(7):711–721. doi: 10.1161/CIRCRESAHA.117.311812
  25. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331(23):1564–1575. doi: 10.1056/NEJM199412083312307
  26. Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American heart association. Circulation. 2016;134(23):e579–e646. doi: 10.1161/CIR.0000000000000455
  27. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381(9862):242–255. doi: 10.1016/S0140-6736(12)60397-3
  28. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell. 2001;104(4):557–567. doi: 10.1016/s0092-8674(01)00242-2
  29. Olivotto I, Girolami F, Ackerman MJ, et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2008;83(6):630–638. doi: 10.4065/83.6.630
  30. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: A position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–276. doi: 10.1093/eurheartj/ehm342
  31. Maron BJ, Ommen SR, Semsarian C, et al. Hypertrophic cardiomyopathy: Present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64(1):83–99. doi: 10.1016/j.jacc.2014.05.003
  32. Chandra A, Skali H, Claggett B, et al. Race- and gender-based differences in cardiac structure and function and risk of heart failure. J Am Coll Cardiol. 2022;79(4):355–368. doi: 10.1016/j.jacc.2021.11.024
  33. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58(25):2703–2738. doi: 10.1016/j.jacc.2011.10.825
  34. Nihoyannopoulos P, Dawson D. Restrictive cardiomyopathies. Eur J Echocardiogr. 2009;10(8):iii23–33. doi: 10.1093/ejechocard/jep156
  35. Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: An updat. Eur Heart J. 2024;45(26):2294–2305. doi: 10.1093/eurheartj/ehae362
  36. Fernández-Solà J. The effects of ethanol on the heart: Alcoholic cardiomyopathy. Nutrients. 2020;12(2):572. doi: 10.3390/nu12020572
  37. Urbano-Marquez A, Estruch R, Navarro-Lopez F, et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320(7):409–415. doi: 10.1056/NEJM198902163200701
  38. Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61–72. doi: 10.1056/NEJMra1509267
  39. Fairweather D, Rose NR. Inflammatory heart disease: A role for cytokines. Lupus. 2005;14(9):646–651. doi: 10.1191/0961203305lu2192oa
  40. Duraes AR, de Souza Lima Bitar Y, Roever L, Neto MG. Endomyocardial fibrosis: Past, present, and future. Heart Fail Rev. 2020;25(5):725–730. doi: 10.1007/s10741-019-09848-4
  41. Sun R, Liu M, Lu L, et al. Congenital heart disease: Causes, diagnosis, symptoms, and treatments. Cell Biochem Biophys. 2015;72(3):857–860. doi: 10.1007/s12013-015-0551-6
  42. Campuzano O, Sarquella-Brugada G, Fernandez-Falgueras A, et al. Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes. EBioMedicine. 2020;54:102732. doi: 10.1016/j.ebiom.2020.102732
  43. Mitchell RN, Ashar FN, Jarvelin MR, et al. Effect of sex and underlying disease on the genetic association of QT interval and sudden cardiac death. J Am Heart Assoc. 2019;8(23):e013751. doi: 10.1161/JAHA.119.013751
  44. Huang J, Wang X, Hao B, et al. Genetic variants in KCNE1, KCNQ1, and NOS1AP in sudden unexplained death during daily activities in Chinese Han population. J Forensic Sci. 2015;60(2):351–356 [published correction appears in J Forensic Sci. 2018 Jan;63(1):349. doi: 10.1111/1556-4029.13725]. doi: 10.1111/1556-4029.12687
  45. Liu Z, Liu X, Yu H, et al. Common variants in TRDN and CALM1 are associated with risk of sudden cardiac death in chronic heart failure patients in Chinese Han population. PLoS One. 2015;10(7):e0132459. doi: 10.1371/journal.pone.0132459
  46. Wang S, Zhang Z, Yang Y, et al. An insertion/deletion polymorphism within 3'UTR of RYR2 modulates sudden unexplained death risk in Chinese populations. Forensic Sci Int. 2017;270:165–172. doi: 10.1016/j.forsciint.2016.12.005
  47. Albert CM, MacRae CA, Chasman DI, et al. Common variants in cardiac Ion channel genes are associated with sudden cardiac death. Circ Arrhythm Electrophysiol. 2010;3(3):222–229. doi: 10.1161/CIRCEP.110.944934
  48. Son MK, Ki CS, Park SJ, et al. Genetic mutation in Korean patients of sudden cardiac arrest as a surrogating marker of idiopathic ventricular arrhythmia. J Korean Med Sci. 2013;28(7):1021–1026. doi: 10.3346/jkms.2013.28.7.1021
  49. Wieneke H, Svendsen JH, Lande J, et al. Polymorphisms in the GNAS gene as predictors of ventricular tachyarrhythmias and sudden cardiac death: Results from the DISCOVERY trial and oregon sudden unexpected death study. J Am Heart Assoc. 2016;5(12):e003905. doi: 10.1161/JAHA.116.003905
  50. Reinier K, Stecker EC, Uy-Evanado A, et al. Sudden cardiac death as first manifestation of heart disease in women: The oregon sudden unexpected death study, 2004–2016. Circulation. 2020;141(7):606–608. doi: 10.1161/CIRCULATIONAHA.119.044169
  51. Adler A, Novelli V, Amin AS, et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome. Circulation. 2020;141(6):418–428. doi: 10.1161/CIRCULATIONAHA.119.043132
  52. Ivanova AA, Maksimov VN. Molecular genetic aspects of sudden cardiac death: A review of the literature. Bulletin of Siberian Medicine. 2018;17(4):209–220. EDN: VQWTRY doi: 10.20538/1682-0363-2018-4-209-220
  53. Narula N, Tester DJ, Paulmichl A, et al. Post-mortem Whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: A case series. Pediatr Cardiol. 2015;36(4):768–778. doi: 10.1007/s00246-014-1082-4
  54. Maksimov VN, Ivanova AA, Orlov PS, et al. Association study of new polymorphisms with sudden cardiac death in men. Russian Journal of Cardiology. 2018;23(10):70–75. EDN: VPZPCI doi: 10.15829/1560-4071-2018-10-70-75
  55. Ivanova AA, Maksimov VN, Moiseeva DI, et al. Single nucleotide variants RS6582147, RS10010305, RS2136810, RS17797829 as new molecular genetic markers of sudden cardiac death. Russian Journal of Cardiology. 2018;23(10):64–69. EDN: VPZPCB doi: 10.15829/1560-4071-2018-10-64-69

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81753 выдано 09.09.2021 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 – 59181 выдано 03.09.2014
г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies